跳至主要内容
临床试验/CTRI/2010/091/001217
CTRI/2010/091/001217已完成4 期

An open label, comparative, multicentric study to evaluate efficacy and safety oflidocaine lozenges vs local lidocaine spray in patients undergoing diagnostic gastroduodenalendoscopy.

Troikaa Pharmaceuticals Ltd Ahmedabad0 个研究点目标入组 250 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
250

研究概览

简要总结

暂无简介。

研究设计

研究类型
Pms

入排标准

入选标准

  • 1. Patients of either sex aged 18-80 years.
  • 2. Patients undergoing diagnostic gastro-duodenal endoscopy.

排除标准

  • 1. Hypersensitivity to lidocaine or any component of the formulation.
  • 2. Any contra-indication to lidocaine.
  • 3. Application on breached mucous membrane.
  • 4. Patients with medical history of respiratory disease such as asthma, bronchitis or chronic obstructive pulmonary disease.
  • 5. Use of another topical product at application site.
  • 6. Unwilling patients.
  • 7. Emergency surgery/ surgery needing hospitalization.
  • 8. H/O alcohol or drug abuse.
  • 9. Clinically significant impairment of hepatic/renal/cardiac functions.
  • 10. Baseline laboratory values outside the clinically acceptable limits.
  • 11. Pregnant women and lactating mothers.
  • 12. Women of child bearing age not practicing contraception.
  • 13. Participation in a clinical study involving an investigational product within past 30 days.

研究者

发起方
Troikaa Pharmaceuticals Ltd Ahmedabad

相似试验